Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Hippuris vulgaris cp genome sequencing raw dara

PROVIDER: PRJNA670584 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12879273.fastq.gz	Fastqsanger.gz
	SRR12879274.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Hippuris vulgaris

Project description:Hippuris vulgaris overview

| PRJNA717859 | ENA

Hippuris vulgaris

Project description:Hippuris vulgaris Genome sequencing and assembly

| PRJNA665557 | ENA

Project description:WGS of Hippuris vulgaris

| PRJNA675915 | ENA

Genome-wide RNA sequencing of D. vulgaris respond to CuO nanoparticles exposure

Project description:Purpose: The objective of this study is to reveal the potential effects of CuO nanoparicles (NPs) on Desulfovibrio vulgaris Hildenborough (D. vulgaris) via genome-wide RNA sequencing Methods: RNA was harvested from D. vulgaris cultures in the presence and absence of CuO NPs (0, 1, 50, 250 mg CuO NPs/L) 8 h after cultivation.

2019-08-01 | GSE101911 | GEO

Whole genome sequencing in cohort of probands with isolated cleft palate

Project description:The identification of the genetic risk factors in patients with isolated cleft palate by whole genome sequencing analysis. Pathogenic or likely pathogenic variants were discovered in genes associated with CP (TBX22, COL2A1, FBN1, PCGF2, and KMT2D) in five patients; hence, rare disease variants were identified in 17% of patients with non-syndromic isolated CP. Our results are relevant to routine genetic counselling practice and genetic testing recommendations.

2022-03-30 | E-MTAB-11360 | biostudies-arrayexpress

Hippuris montana

Project description:Hippuris montana Raw sequence reads

| PRJNA939090 | ENA

Hippuris montana

Project description:Hippuris montana Raw sequence reads

| PRJNA939094 | ENA

Ralstonia sp. CP strain:CP

Project description:Ralstonia sp. CP strain:CP Genome sequencing

| PRJNA1131907 | ENA

Project description:cp genome sequencing

| PRJNA716742 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data